• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗地亚缺血性脑卒中的成本。

The cost of ischaemic stroke in Croatia.

机构信息

Croatian Society for Pharmacoeconomics and Health Economics, Zagreb, Croatia.

Zem Solutions Ltd., Belgrade, Serbia.

出版信息

Eur Stroke J. 2023 Jan;8(1 Suppl):21-27. doi: 10.1177/23969873221123840. Epub 2023 Feb 10.

DOI:10.1177/23969873221123840
PMID:36793741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9923131/
Abstract

OBJECTIVE

The aim of this analysis was to estimate 1 year and long-term cost and quality of life of ischaemic stroke patients in Croatia. In addition, we aimed to identify and estimate key categories of costs and outcomes driving the burden of stroke in Croatian healthcare system.

METHODS

Data were derived from analysis of the RES-Q Registry for Croatia in 2018 and supplemented with clinical expert opinion and relevant medical, clinical and economic literature to estimate the course of the disease and treatment patterns in Croatian healthcare system. The health economic model was comprised of a one-year discrete event simulation (DES) mapping real life patient experience and a 10-year Markov model built on existing literature. Cost and health resources use were obtained using Croatian tariffs. Health utilities were mapped to EQ5D from the Barthel Index utilising previously published studies.

RESULTS

The key aspects determining costs and quality of life were rehabilitation, discharge to residential care (currently 13% of patients in Croatia) and recurrent stroke. Total 1 year cost per patient was 18,221 EUR having 0.372 QALYs.

CONCLUSION

Direct costing structure of ischaemic stroke in Croatia is above the value of upper-middle income countries. Our study showed that post stroke rehabilitation seems to be a strong modifier of future post-stroke costs and further research into various models of post-stroke care and rehabilitation could be the answer into more successful rehabilitation that could increase QALY and reduce the economic burden of stroke. Further investment in rehabilitation research and provision might bring promising opportunities to improve long term patient outcomes.

摘要

目的

本分析旨在评估克罗地亚缺血性脑卒中患者的 1 年和长期成本及生活质量。此外,我们旨在确定和评估导致克罗地亚医疗保健系统中脑卒中负担的关键成本和结果类别。

方法

数据来自 2018 年 RES-Q 克罗地亚登记处的分析,并结合临床专家意见和相关医疗、临床和经济文献,以估计疾病的进程和克罗地亚医疗保健系统中的治疗模式。该健康经济模型由一年的离散事件模拟(DES)组成,该模拟反映了现实生活中患者的体验,以及基于现有文献建立的十年马尔可夫模型。使用克罗地亚关税获得成本和健康资源的使用情况。健康效用值通过先前发表的研究,从巴氏指数映射到 EQ5D。

结果

决定成本和生活质量的关键因素是康复、转至养老院(目前克罗地亚有 13%的患者)和再次发生脑卒中。每位患者的 1 年总成本为 18221 欧元,具有 0.372 个质量调整生命年。

结论

克罗地亚缺血性脑卒中的直接成本结构高于中上收入国家的水平。我们的研究表明,脑卒中后的康复似乎是未来脑卒中后成本的重要修正因素,进一步研究各种脑卒中后护理和康复模式可能是提高康复成功率的答案,这可以提高质量调整生命年并降低脑卒中的经济负担。进一步投资于康复研究和提供可能会带来改善长期患者预后的有前景的机会。

相似文献

1
The cost of ischaemic stroke in Croatia.克罗地亚缺血性脑卒中的成本。
Eur Stroke J. 2023 Jan;8(1 Suppl):21-27. doi: 10.1177/23969873221123840. Epub 2023 Feb 10.
2
Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective.急性缺血性卒中血管内治疗延迟对终身生活质量和成本的影响:从新加坡医疗保健角度进行的成本效益分析。
BMJ Open. 2020 Sep 17;10(9):e036517. doi: 10.1136/bmjopen-2019-036517.
3
An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.一项针对中风患者的扩展中风康复服务:EXTRAS RCT。
Health Technol Assess. 2020 May;24(24):1-202. doi: 10.3310/hta24240.
4
Cost-effectiveness of tenecteplase versus alteplase for stroke thrombolysis evaluation trial in the ambulance.救护车中 tenecteplase 与 alteplase 溶栓评估试验的成本效益
Eur Stroke J. 2023 Jun;8(2):448-455. doi: 10.1177/23969873231165086. Epub 2023 Mar 26.
5
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.氯吡格雷和双嘧达莫缓释制剂预防闭塞性血管事件(技术评估 90 号回顾):系统评价和经济分析。
Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310.
6
7
The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.意大利脑卒中幸存者的社会经济负担:一项前瞻性、基于发病率的多中心疾病成本研究。
BMC Neurol. 2012 Nov 14;12:137. doi: 10.1186/1471-2377-12-137.
8
Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.克罗地亚老年缺血性卒中房颤患者药物基因组学指导下华法林治疗的经济学评价
Pharmacogenomics. 2015 Jan;16(2):137-48. doi: 10.2217/pgs.14.167.
9
The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.缺血性卒中对房颤相关医疗费用的影响:系统评价。
Europace. 2017 Jun 1;19(6):937-947. doi: 10.1093/europace/euw093.
10
Moving the Brazilian ischaemic stroke pathway to a value-based care: introduction of a risk-adjusted cost estimate model for stroke treatment.将巴西缺血性脑卒中治疗路径转移到基于价值的护理:引入脑卒中治疗的风险调整成本估算模型。
Health Policy Plan. 2022 Oct 12;37(9):1098-1106. doi: 10.1093/heapol/czac058.

引用本文的文献

1
Inhibition of Pyroptosis by Hydroxychloroquine as a Neuroprotective Strategy in Ischemic Stroke.羟氯喹抑制细胞焦亡作为缺血性脑卒中的神经保护策略
eNeuro. 2024 Dec 18;12(1). doi: 10.1523/ENEURO.0254-24.2024.
2
Global, Regional, and National Economic Consequences of Stroke.全球、区域和国家的卒中经济后果。
Stroke. 2023 Sep;54(9):2380-2389. doi: 10.1161/STROKEAHA.123.043131. Epub 2023 Jul 27.

本文引用的文献

1
The economic burden of stroke: a systematic review of cost of illness studies.卒中的经济负担:疾病成本研究的系统综述。
J Med Life. 2021 Sep-Oct;14(5):606-619. doi: 10.25122/jml-2021-0361.
2
Telerehabilitation: Has Its Time Come?远程康复:时机已到?
Stroke. 2021 Aug;52(8):2694-2696. doi: 10.1161/STROKEAHA.121.033289. Epub 2021 Jul 1.
3
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.《2021年卒中与短暂性脑缺血发作患者卒中预防指南:美国心脏协会/美国卒中协会指南》
Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24.
4
mHealth Intervention Applications for Adults Living With the Effects of Stroke: A Scoping Review.针对中风后遗症成年患者的移动健康干预应用:一项范围综述
Arch Rehabil Res Clin Transl. 2020 Dec 16;3(1):100095. doi: 10.1016/j.arrct.2020.100095. eCollection 2021 Mar.
5
Pre-stroke disability and stroke severity as predictors of discharge destination from an acute stroke ward.卒中前残疾和卒中严重程度作为急性卒中病房出院目的地的预测因素。
Clin Med (Lond). 2021 Mar;21(2):e186-e191. doi: 10.7861/clinmed.2020-0834.
6
Is Endovascular Therapy for Stroke Cost-Effective Globally? A Systematic Review of the Literature.血管内治疗对全球范围内的中风是否具有成本效益?文献系统评价。
J Stroke Cerebrovasc Dis. 2021 Apr;30(4):105557. doi: 10.1016/j.jstrokecerebrovasdis.2020.105557. Epub 2021 Feb 5.
7
Cost and cost-effectiveness of early inpatient rehabilitation after stroke varies with initial disability: the Czech Republic perspective.卒中后早期住院康复的成本和成本效益因初始残疾程度而异:捷克共和国的观点。
Int J Rehabil Res. 2020 Dec;43(4):376-382. doi: 10.1097/MRR.0000000000000440.
8
Burden of Stroke in Europe: Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years.欧洲的卒中负担:发病率、患病率、死亡率和伤残调整生命年的 30 年预测。
Stroke. 2020 Aug;51(8):2418-2427. doi: 10.1161/STROKEAHA.120.029606. Epub 2020 Jul 10.
9
Enhancing and accelerating stroke treatment in Eastern European region: Methods and achievement of the ESO EAST program.加强和加速东欧地区的卒中治疗:欧洲卒中组织东欧项目的方法与成果
Eur Stroke J. 2020 Jun;5(2):204-212. doi: 10.1177/2396987319897156. Epub 2020 Jan 20.
10
Costs structure of the inpatient ischemic stroke treatment using an exact costing method.采用精确成本核算方法的缺血性中风住院治疗成本结构。
Heliyon. 2020 Jun 23;6(6):e04264. doi: 10.1016/j.heliyon.2020.e04264. eCollection 2020 Jun.